IMARC Group’s latest report, titled “Cysteine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global cysteine market size reached US$ 368 Million in 2021. Cysteine refers to a non-essential sulfur-containing amino acid in humans found in beta-keratin, the main protein in skin, hair, and nails. It is manufactured through the hydrolysis of proteins in the presence of carbon dioxide. It is mainly used for protein synthesis, detoxification, and numerous metabolic functions. It is a component of the antioxidant glutathione and plays a crucial role in the metabolism of essential biochemicals, including coenzyme A, heparin, and biotin. It also helps reduce the risks of developing cancer, diabetes, and cardiovascular diseases (CVDs). Since it is a rich source of antioxidants, it assists in collagen production, improving skin elasticity and texture, reducing inflammation and cell damage, and reversing the signs of aging. Apart from this, cysteine is widely employed as a reducing agent in manufacturing pharmaceuticals, cosmetic and personal care products, food supplements, and flavor enhancers.
Global Cysteine Market Trends:
The emerging product applications across various industries represent the primary factor driving market growth. For instance, in the pharmaceutical sector, cysteine is extensively utilized for total parenteral nutrition and as an antidote for acetaminophen overdose. Besides this, it also aids in treating metabolic disorders and malabsorption syndromes. In addition, there has been a rise in product usage in the food industry as a dough conditioner and strengthener to break the disulfide bonds of gluten and reduce the viscosity of dough in bakery products. Along with this, the increasing consumption of baked goods and the growing adoption of cysteine as a flavoring agent and nutritional supplement have augmented the product demand. Furthermore, there is an increase in the use of cysteine in cosmetics and personal care products as a fragrance ingredient and anti-static, conditioning, and waving agent in hair care products. In line with this, the surging product applications as a veterinary detoxicant and medication have catalyzed the market growth. Other factors, including the rapid expansion in the pharmaceutical sector, rising demand for plant-based cysteine products, the emerging trend of veganism, inflating consumer purchasing power, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 495 Million by 2027, growing at a CAGR of 5.19% during 2022-2027.
Market Summary:
- Based on the production process, the market has been bifurcated into natural and synthetic.
- On the basis of the application, the market has been categorized into conditioner, flavor enhancer, reducing agent, human insulin production, and others.
- The market has been divided based on the end use industry into food and dietary supplement, pharmaceutical, cosmetic, animal feed, and others.
- Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.), and Wuxi Bikang Bioengineering Co. Ltd.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800